ESSA Pharma Cash And Short Term Investments Over Time

EPIX Stock  USD 1.60  0.01  0.62%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out ESSA Pharma Performance and ESSA Pharma Correlation.
For more information on how to buy ESSA Stock please use our How to Invest in ESSA Pharma guide.
  
Cash And Short Term Investments is likely to rise to about 133.1 M in 2024.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ESSA Pharma. If investors know ESSA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ESSA Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.64)
Return On Assets
(0.15)
Return On Equity
(0.20)
The market value of ESSA Pharma is measured differently than its book value, which is the value of ESSA that is recorded on the company's balance sheet. Investors also form their own opinion of ESSA Pharma's value that differs from its market value or its book value, called intrinsic value, which is ESSA Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ESSA Pharma's market value can be influenced by many factors that don't directly affect ESSA Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ESSA Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ESSA Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ESSA Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Cash And Short Term Investments Analysis

Compare ESSA Pharma and related stocks such as Altamira Therapeutics, Summit Therapeutics PLC, and Avenue Therapeutics Cash And Short Term Investments Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
Inventory TurnoverNet Income Per Share
Days Of Inventory On HandPayables Turnover
Sales General And Administrative To RevenueAverage Inventory
Research And Ddevelopement To RevenueCapex To Revenue
Cash Per SharePocfratio
Interest CoveragePayout Ratio
Capex To Operating Cash FlowPfcf Ratio
Days Payables OutstandingNet Current Asset Value
Income QualityRoe
Tangible Asset ValueEv To Operating Cash Flow
Pe RatioReturn On Tangible Assets
Ev To Free Cash FlowEarnings Yield
Intangibles To Total AssetsNet Debt To E B I T D A
Current RatioTangible Book Value Per Share
Receivables TurnoverGraham Number
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D ARoic
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Cash Conversion Cycle
201020112012201320142015201620172018201920202021202220232024
CYTO825.7 K825.7 K64 K23.9 M56.9 M50.2 M32.4 M15 M5.4 M1.4 M11.3 M984.2 K15.4 K617.4 K586.5 K
SMMT146 K3.3 M5.3 M3.3 M17 M23.2 M35.1 M28.5 M35.2 M64.1 M66.4 M71.8 M348.6 M186.2 M195.6 M
ATXI14 K14 K14 K14 K14 K14 K197 K21.8 M2.7 M8.7 M3.1 M3.8 M6.7 M1.8 M1.7 M
SPRO5.7 M5.7 M5.7 M5.7 M5.7 M5.7 M10.3 M87.3 M115.4 M82 M126.9 M146.4 M109.1 M76.3 M92.8 M

ESSA Pharma and related stocks such as Altamira Therapeutics, Summit Therapeutics PLC, and Avenue Therapeutics Cash And Short Term Investments description

Short Term Investments is an account in the current assets section of ESSA Pharma balance sheet. This account contains ESSA Pharma investments that will expire within one year. These investments include stocks and bonds that can be liquidated by ESSA Pharma fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

My Equities

My Current Equities and Potential Positions

ESSA Pharma
EPIX
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationBritish Columbia; Canada
ExchangeNASDAQ Exchange
USD 1.6

Additional Tools for ESSA Stock Analysis

When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.